Tuesday , October 4 2022

New Mexican Creates Chlamydia Diagnostic Device (5 PM) <ADN – Agencia Digital de Noticias Southeast



[ad_1]

Oaxaca de Juárez, November 17. In the Innovators Under 35 LATAM 2018, Mexican Ishtar Rizzo presented his Chlamydia diagnostic device that could improve the sexual health of the population.Chlamydia

In an exclusive interview with Notimex, Rizzo, co-founder of LIZA, explained that it represents a start that aims to help improve sexual health through a device that makes diagnosis of sexually transmitted infections (ITS) easier and more private.

Initially from Orizaba, Veracruz, Ishtar, one of the 35 youngsters selected to be awarded by the MIT Technology Review, said it was seeking to provide the population with the ability to test quickly for the detection of STIs in a non-invasive manner.

He reported that the diagnosis of Chlamydia infection is relatively simple, but penetrating and sometimes painful, because it usually requires taking a sample of the epithelium within the genital system.

"The LIZA has an innovative design that allows you to comfortably collect the original urine fraction and dispose of the rest without having to stop urinating or other discomfort," he said.

He added that this sample passes through the device itself through various membranes that manage to collect the epithelial cells captured along with the urine, dissolve them and detect the presence of the bacteria that cause the disease.

He said the intention is that this device can be purchased at all pharmacies, as with a pregnancy test, so that the person can diagnose quickly, painlessly and particularly privately.

He believed that using personal devices such as LIZA could eliminate the obstacle that exists after a social stigma in those people who are coming for sexually transmitted diseases.

He also emphasized the idea that in the future other diseases of a similar nature, such as gonorrhea or syphilis, can be identified in the privacy of the home. "At present, the test we have is about chlamydia, we are in ratifying the sensitivity rate."




[ad_2]
Source link